The permanence of rt-PCR positivity after a long time in COVID-19 patients has prompted
the question of whether SARS-CoV-2 could cause a persistent infection or patients can …

Characterisation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic
diversity through space and time can reveal trends in virus importation and domestic …

Although dengue is typically considered an urban disease, rural communities are also at
high risk. To clarify dynamics of dengue virus (DENV) transmission in settings with …

Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection have
been reported in Hong Kong, Belgium, the Netherlands, and the USA. 1–4 Here we report the …

SARS-CoV-2, the etiological agent of COVID-19 was first described in Wuhan in December
2019 and has now spread globally. Ecuador was the second country in South America to …

SARS-CoV-2, the etiological agent of COVID-19, was first described in Wuhan, China in
December 2019 and has now spread globally. Ecuador was the second country in South …

Dengue is recognized as a major health issue in large urban tropical cities but is also
observed in rural areas. In these environments, physical characteristics of the landscape and …

Oropouche virus (OROV) is responsible for outbreaks of Oropouche fever in parts of South
America. We recently identified and isolated OROV from a febrile Ecuadorian patient, however…

We report identification of an Oropouche virus strain in a febrile patient from Ecuador by
using metagenomic sequencing and real-time reverse transcription PCR. Virus was isolated …

The only licensed dengue vaccine, Dengvaxia ® , increases risk of severe dengue when
given to individuals without prior dengue virus (DENV) infection but is protective against future …